drugset / Trial / NCT00290056

Effect of Supplemental Intake of Omega-3 Polyunsaturated Fatty Acids on the Rate and Complexity of Spontaneously Occurring Ventricular and Supraventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillator (ICD) - A Randomized Clinical Trial

NCT00290056

Phase 4 Unknown 105 enrolled Sheba Medical Center
RandomizedCrossoverDouble-blindTreatment

Summary

We hypothesize that oral supplementation with omega-3 PUFA will decrease occurrence of arrhythmic events among post-MI, ICD recipients.

Timeline

Start
2005-11
Primary completion
2009-11
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject DOCONEXENT Other / unclassified Oral
Subject Eicosapentanoic acid Other / unclassified Oral